Amlodipine Besylate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Amlodipine Besylate
US Patents

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Amlodipine Besylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

110 API Suppliers, 41 USDMF, 43 CEP/COS, 25 JDMF, 25 EU WC, 92 KDMF, 26 NDC API, 54 Listed Suppliers, $ API Reference Price

110 API Suppliers
41 USDMF
43 CEP/COS
25 JDMF
25 EU WC
92 KDMF
26 NDC API
54 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

6 Intermediates Suppliers

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

765 FDF Dossiers, 424 FDA Orange Book, 47 Europe, 134 Canada, 34 South Africa, 126 Listed Dossiers

765 FDF Dossiers
424 FDA Orange Book
47 Europe
134 Canada
34 South Africa
126 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE, TABLET;ORAL - EQ 5MG BASE, CAPSULE;ORAL - EQ 10MG BASE;20MG, CAPSULE;ORAL - EQ 10MG BASE;40MG, CAPSULE;ORAL - EQ 2.5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;20MG, CAPSULE;ORAL - EQ 5MG BASE;40MG, TABLET;ORAL - EQ 10MG BASE;14MG, TABLET;ORAL - EQ 2.5MG BASE;3.5MG, TABLET;ORAL - EQ 5MG BASE;7MG, TABLET;ORAL - EQ 10MG BASE;200MG, TABLET;ORAL - EQ 2.5MG BASE;200MG, TABLET;ORAL - EQ 5MG BASE;200MG, TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 10MG BASE;160MG, TABLET;ORAL - EQ 10MG BASE;320MG, TABLET;ORAL - EQ 5MG BASE;160MG, TABLET;ORAL - EQ 5MG BASE;320MG, TABLET;ORAL - EQ 10MG BASE;20MG, TABLET;ORAL - EQ 10MG BASE;40MG, TABLET;ORAL - EQ 5MG BASE;20MG, TABLET;ORAL - EQ 5MG BASE;40MG, TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;320MG, TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 5MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 2.5MG BASE
TABLET;ORAL - EQ 5MG BASE
CAPSULE;ORAL - EQ 10MG BASE;20MG
CAPSULE;ORAL - EQ 10MG BASE;40MG
CAPSULE;ORAL - EQ 2.5MG BASE;10MG
CAPSULE;ORAL - EQ 5MG BASE;10MG
CAPSULE;ORAL - EQ 5MG BASE;20MG
CAPSULE;ORAL - EQ 5MG BASE;40MG
TABLET;ORAL - EQ 10MG BASE;14MG
TABLET;ORAL - EQ 2.5MG BASE;3.5MG
TABLET;ORAL - EQ 5MG BASE;7MG
TABLET;ORAL - EQ 10MG BASE;200MG
TABLET;ORAL - EQ 2.5MG BASE;200MG
TABLET;ORAL - EQ 5MG BASE;200MG
TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE
TABLET;ORAL - EQ 10MG BASE;160MG
TABLET;ORAL - EQ 10MG BASE;320MG
TABLET;ORAL - EQ 5MG BASE;160MG
TABLET;ORAL - EQ 5MG BASE;320MG
TABLET;ORAL - EQ 10MG BASE;20MG
TABLET;ORAL - EQ 10MG BASE;40MG
TABLET;ORAL - EQ 5MG BASE;20MG
TABLET;ORAL - EQ 5MG BASE;40MG
TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;320MG
TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 5MG BASE;25MG;160MG
TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Rochem International Inc, 21 SPI Pharma, 2 Seqens, 19 DKSH, 3 Jai Radhe Sales, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 2 Aeon Procare, 3 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 35 BASF, 3 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 55 Direct Compression, 48 Disintegrants & Superdisintegrants, 43 Thickeners and Stabilizers, 38 Solubilizers, 35 Controlled & Modified Release, 33 Lubricants & Glidants, 32 Granulation, 27 Topical, 24 Parenteral, 24 Film Formers & Plasticizers, 22 Co-Processed Excipients, 21 Chewable & Orodispersible Aids, 19 Taste Masking, 13 Emulsifying Agents, 10 API Stability Enhancers, 10 Rheology Modifiers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

113 Fillers, Diluents & Binders
60 Coating Systems & Additives
55 Direct Compression
48 Disintegrants & Superdisintegrants
43 Thickeners and Stabilizers
38 Solubilizers
35 Controlled & Modified Release
33 Lubricants & Glidants
32 Granulation
27 Topical
24 Parenteral
24 Film Formers & Plasticizers
22 Co-Processed Excipients
21 Chewable & Orodispersible Aids
19 Taste Masking
13 Emulsifying Agents
10 API Stability Enhancers
10 Rheology Modifiers
9 Empty Capsules
8 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 40 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
40 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 40 Finished Drug Prices, 1 Annual Reports

6 US Medicaid Prescriptions
40 Finished Drug Prices
1 Annual Reports

MARKET PLACE

35 APIs, 7 FDF Dossiers

35 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

33 US Patents, 6 Health Canada Patents

33 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 1 USP, 7 JP, 1 Others

5 EDQM
1 USP
7 JP
1 Others

$ API Ref.Price (USD/KG) : 117 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

33 All

01 3ADHERA

02 11CMP DEV LLC

03 4NOVARTIS

04 15PURPLE BIOTECH

filter Patent Number Reset all filters

33 All

01 37846961

02 48613949

03 39408837

04 39662315

05 310350171

06 310925835

07 310945960

08 311253474

09 311458095

10 311723866

11 212005141

filter API Patent Reset all filters

33 All

01 3Y

02 30Blank

filter FDF Patent Reset all filters

33 All

01 27Y

02 6Blank

filter Expiration Date Reset all filters

33 All

01 32029-05-22

02 32029-10-05

03 42029-12-21

04 32030-02-28

05 92038-06-14

06 112041-02-24

Product Main Page

01

ADHERA

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

Pharmtech & Ingredients

Not Confirmed

ADHERA

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-05

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

US Patent Number : 7846961

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205003

Patent Use Code : U-3

Delist Requested :

Patent Use Description : TREATMENT OF HYPERTENS...

Patent Expiration Date : 2029-10-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ADHERA

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

Pharmtech & Ingredients

Not Confirmed

ADHERA

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-05

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

US Patent Number : 7846961

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205003

Patent Use Code : U-3

Delist Requested :

Patent Use Description : TREATMENT OF HYPERTENS...

Patent Expiration Date : 2029-10-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ADHERA

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

Pharmtech & Ingredients

Not Confirmed

ADHERA

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-05

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

US Patent Number : 7846961

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205003

Patent Use Code : U-3

Delist Requested :

Patent Use Description : TREATMENT OF HYPERTENS...

Patent Expiration Date : 2029-10-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

CMP DEV LLC

AMLODIPINE BESYLATE

Pharmtech & Ingredients

Not Confirmed

CMP DEV LLC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-02-24

AMLODIPINE BESYLATE

US Patent Number : 11458095

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214439

Patent Use Code : U-3309

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

CMP DEV LLC

AMLODIPINE BESYLATE

Pharmtech & Ingredients

Not Confirmed

CMP DEV LLC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-02-24

AMLODIPINE BESYLATE

US Patent Number : 11458095

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214439

Patent Use Code : U-3310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

CMP DEV LLC

AMLODIPINE BESYLATE

Pharmtech & Ingredients

Not Confirmed

CMP DEV LLC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-02-24

AMLODIPINE BESYLATE

US Patent Number : 11458095

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214439

Patent Use Code : U-3311

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

CMP DEV LLC

AMLODIPINE BESYLATE

Pharmtech & Ingredients

Not Confirmed

CMP DEV LLC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-02-24

AMLODIPINE BESYLATE

US Patent Number : 12005141

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214439

Patent Use Code : U-3309

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

CMP DEV LLC

AMLODIPINE BESYLATE

Pharmtech & Ingredients

Not Confirmed

CMP DEV LLC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-02-24

AMLODIPINE BESYLATE

US Patent Number : 12005141

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214439

Patent Use Code : U-3310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

CMP DEV LLC

AMLODIPINE BESYLATE

Pharmtech & Ingredients

Not Confirmed

CMP DEV LLC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-02-24

AMLODIPINE BESYLATE

US Patent Number : 11723866

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214439

Patent Use Code : U-3309

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

CMP DEV LLC

AMLODIPINE BESYLATE

Pharmtech & Ingredients

Not Confirmed

CMP DEV LLC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-02-24

AMLODIPINE BESYLATE

US Patent Number : 11723866

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214439

Patent Use Code : U-3311

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?